Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Isotope & Radiation Corp. ( (HK:1763) ) has issued an update.
China Isotope & Radiation Corporation announced the results of its Annual General Meeting (AGM) held on June 3, 2025, where all proposed resolutions were approved by shareholders. Key decisions included the dissolution of the supervisory committee, resignation of supervisors, and the approval of a final dividend distribution of RMB0.3090 per share for the fiscal year 2024. These developments are expected to streamline the company’s governance structure and provide financial returns to shareholders, reinforcing its market position.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology application industry, focusing on the production and distribution of radioactive isotopes and radiation processing services. The company is a key player in the Chinese market, providing essential products and services for medical, industrial, and scientific applications.
Average Trading Volume: 336,246
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.16B
For detailed information about 1763 stock, go to TipRanks’ Stock Analysis page.